Key Details
Price
$21.85PE Ratio
16.68Annual ROE
29.38%Beta
1.07Events Calendar
Next earnings date:
May 8, 2025Recent quarterly earnings:
Feb 26, 2025Recent annual earnings:
Feb 26, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 3, 25 Baird
OutperformFeb 28, 25 HC Wainwright & Co.
BuyFeb 27, 25 Stephens & Co.
OverweightFeb 4, 25 Baird
OutperformJan 10, 25 HC Wainwright & Co.
BuyJan 9, 25 B of A Securities
BuyNov 18, 24 Stephens & Co.
OverweightNov 11, 24 Truist Securities
BuyNov 8, 24 HC Wainwright & Co.
BuyAug 12, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Catalyst Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Catalyst Pharmaceuticals?
- Does Catalyst Pharmaceuticals pay dividends?
- What sector is Catalyst Pharmaceuticals in?
- What industry is Catalyst Pharmaceuticals in?
- What country is Catalyst Pharmaceuticals based in?
- When did Catalyst Pharmaceuticals go public?
- Is Catalyst Pharmaceuticals in the S&P 500?
- Is Catalyst Pharmaceuticals in the NASDAQ 100?
- Is Catalyst Pharmaceuticals in the Dow Jones?
- When was Catalyst Pharmaceuticals's last earnings report?
- When does Catalyst Pharmaceuticals report earnings?
- Should I buy Catalyst Pharmaceuticals stock now?
What is the ticker symbol for Catalyst Pharmaceuticals?
The ticker symbol for Catalyst Pharmaceuticals is NASDAQ:CPRX
Does Catalyst Pharmaceuticals pay dividends?
No, Catalyst Pharmaceuticals does not pay dividends
What sector is Catalyst Pharmaceuticals in?
Catalyst Pharmaceuticals is in the Healthcare sector
What industry is Catalyst Pharmaceuticals in?
Catalyst Pharmaceuticals is in the Biotechnology industry
What country is Catalyst Pharmaceuticals based in?
Catalyst Pharmaceuticals is headquartered in United States
When did Catalyst Pharmaceuticals go public?
Catalyst Pharmaceuticals's initial public offering (IPO) was on November 8, 2006
Is Catalyst Pharmaceuticals in the S&P 500?
No, Catalyst Pharmaceuticals is not included in the S&P 500 index
Is Catalyst Pharmaceuticals in the NASDAQ 100?
No, Catalyst Pharmaceuticals is not included in the NASDAQ 100 index
Is Catalyst Pharmaceuticals in the Dow Jones?
No, Catalyst Pharmaceuticals is not included in the Dow Jones index
When was Catalyst Pharmaceuticals's last earnings report?
Catalyst Pharmaceuticals's most recent earnings report was on Feb 26, 2025
When does Catalyst Pharmaceuticals report earnings?
The next expected earnings date for Catalyst Pharmaceuticals is May 8, 2025
Should I buy Catalyst Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions